1. Home
  2. SCYX vs AVX Comparison

SCYX vs AVX Comparison

Compare SCYX & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$3.79

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo Avax One Technology Ltd.

AVX

Avax One Technology Ltd.

HOLD

Current Price

$4.16

Market Cap

30.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCYX
AVX
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
30.8M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SCYX
AVX
Price
$3.79
$4.16
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $36.33
N/A
AVG Volume (30 Days)
★ 284.7K
245.0K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
61.36
★ 92.55
EPS
★ N/A
N/A
Revenue
$257,000.00
★ $2,340,811.00
Revenue This Year
N/A
$18,042.77
Revenue Next Year
$977.86
$12.21
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 3348.10
52 Week Low
$0.66
$0.35
52 Week High
$6.09
$7.38

Technical Indicators

Market Signals
Indicator
SCYX
AVX
Relative Strength Index (RSI) 39.78 44.13
Support Level $3.53 $3.02
Resistance Level $4.30 $6.25
Average True Range (ATR) 0.23 0.65
MACD -0.02 -0.18
Stochastic Oscillator 23.92 16.50

Price Performance

Historical Comparison
SCYX
AVX

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.

Share on Social Networks: